Guidance Document: Regulatory Requirements for Drug Identification Numbers (DINs) - Summary

From Health Canada

Overview

This guidance document provides:

  1. assistance on the interpretation of the regulatory requirements associated with a DIN
  2. guidance to manufacturers on their obligation to accurately report to Health Canada the following notifications for a change of drug status within the required timelines:
    • Market notification
    • 12 months without sale notification
    • Discontinuation of sale notification

In this guide

View complete guide
Download PDF (500 KB, 33 pages)

Details and history

Administrative changes date: May 1, 2024

Published: May 3, 2019

Consulted: January 25, 2019

Part of topic: Guidance on legislation

For assistance

Our service hours are Monday to Friday from 8 a.m. to 6 p.m. (local time) and closed statuary holidays.

Contact us by email:

DIN@hc-sc.gc.ca

Page details

Date modified: